US Tech 100

20,184.40

-0.23%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

KRON Kronos Bio Inc

0.888

-0.015 (-1.66%)

Nov 25 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Kronos Bio (NASDAQ:KRON)
Historical Stock Chart
From Oct 2024 to Nov 2024

Kronos Bio (NASDAQ:KRON)
Historical Stock Chart
From Nov 2023 to Nov 2024

Kronos Bio Inc News

Form EFFECT - Notice of Effectiveness
Thursday 14 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024
Thursday 14 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 13 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives
Wednesday 13 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Thursday 7 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma
Tuesday 5 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors
Wednesday 23 October 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 15 October 2024 (1 month ago) • Edgar (US Regulatory)

Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors
Wednesday 9 October 2024 (2 months ago) • GlobeNewswire Inc.

Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren’s Disease
Monday 7 October 2024 (2 months ago) • GlobeNewswire Inc.

Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy
Wednesday 25 September 2024 (2 months ago) • GlobeNewswire Inc.

	Real-time Prices	Level 2
Dow Jones Indices
Toronto Stock Exchange
Toronto Stock Exchange Venture Exchange
OTCBB
New York Stock Exchange
NASDAQ
American Stock Exchange
OTCMarkets
Canadian Securities Exchange
OPRA
OPRA Indices
Forex

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

KRON Kronos Bio Inc

Kronos Bio Inc News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

KRON Kronos Bio Inc

Kronos Bio Inc News

Your Recent History

Company

Business

Popular

Get The App

BLACK FRIDAY

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%